This company has been marked as potentially delisted and may not be actively trading. (ANTX) (ANTX) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesTrendsBuy This Stock ANTX vs. GLSI, ASMB, HURA, MGNX, THTX, CTNM, ATOS, BHST, ANIX, and CRBPShould you be buying (ANTX) stock or one of its competitors? The main competitors of (ANTX) include Greenwich LifeSciences (GLSI), Assembly Biosciences (ASMB), TuHURA Biosciences (HURA), MacroGenics (MGNX), Theratechnologies (THTX), Contineum Therapeutics (CTNM), Atossa Therapeutics (ATOS), BioHarvest Sciences (BHST), Anixa Biosciences (ANIX), and Corbus Pharmaceuticals (CRBP). These companies are all part of the "pharmaceutical preparations" industry. (ANTX) vs. Its Competitors Greenwich LifeSciences Assembly Biosciences TuHURA Biosciences MacroGenics Theratechnologies Contineum Therapeutics Atossa Therapeutics BioHarvest Sciences Anixa Biosciences Corbus Pharmaceuticals (ANTX) (NYSE:ANTX) and Greenwich LifeSciences (NASDAQ:GLSI) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, media sentiment, analyst recommendations, community ranking, profitability, risk, valuation, institutional ownership and dividends. Is ANTX or GLSI more profitable? (ANTX)'s return on equity of -57.62% beat Greenwich LifeSciences' return on equity.Company Net Margins Return on Equity Return on Assets (ANTX)N/A -57.62% -52.08% Greenwich LifeSciences N/A -185.12%-164.27% Do analysts rate ANTX or GLSI? (ANTX) currently has a consensus target price of $1.50, indicating a potential upside of 39.53%. Greenwich LifeSciences has a consensus target price of $39.00, indicating a potential upside of 323.91%. Given Greenwich LifeSciences' stronger consensus rating and higher possible upside, analysts plainly believe Greenwich LifeSciences is more favorable than (ANTX).Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score (ANTX) 1 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Greenwich LifeSciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger earnings & valuation, ANTX or GLSI? Greenwich LifeSciences is trading at a lower price-to-earnings ratio than (ANTX), indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio(ANTX)N/AN/A-$64.73M-$2.04-0.53Greenwich LifeSciencesN/AN/A-$8.89M-$1.26-7.30 Does the MarketBeat Community favor ANTX or GLSI? (ANTX) received 88 more outperform votes than Greenwich LifeSciences when rated by MarketBeat users. Likewise, 58.08% of users gave (ANTX) an outperform vote while only 47.37% of users gave Greenwich LifeSciences an outperform vote. CompanyUnderperformOutperform(ANTX)Outperform Votes9758.08% Underperform Votes7041.92% Greenwich LifeSciencesOutperform Votes947.37% Underperform Votes1052.63% Does the media refer more to ANTX or GLSI? In the previous week, Greenwich LifeSciences had 1 more articles in the media than (ANTX). MarketBeat recorded 1 mentions for Greenwich LifeSciences and 0 mentions for (ANTX). Greenwich LifeSciences' average media sentiment score of 1.87 beat (ANTX)'s score of 0.00 indicating that Greenwich LifeSciences is being referred to more favorably in the news media. Company Overall Sentiment (ANTX) Neutral Greenwich LifeSciences Very Positive Do institutionals & insiders hold more shares of ANTX or GLSI? 90.5% of (ANTX) shares are owned by institutional investors. Comparatively, 4.2% of Greenwich LifeSciences shares are owned by institutional investors. 20.8% of (ANTX) shares are owned by company insiders. Comparatively, 51.7% of Greenwich LifeSciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has more volatility & risk, ANTX or GLSI? (ANTX) has a beta of 0.15, suggesting that its stock price is 85% less volatile than the S&P 500. Comparatively, Greenwich LifeSciences has a beta of 1.69, suggesting that its stock price is 69% more volatile than the S&P 500. SummaryGreenwich LifeSciences beats (ANTX) on 8 of the 14 factors compared between the two stocks. Get (ANTX) News Delivered to You Automatically Sign up to receive the latest news and ratings for ANTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ANTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANTX vs. The Competition Export to ExcelMetric(ANTX)Pharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$33.76M$6.88B$5.57B$19.67BDividend YieldN/A2.52%5.28%3.81%P/E Ratio-0.538.5026.7134.98Price / SalesN/A263.12407.7742.85Price / CashN/A65.8538.2517.51Price / Book0.266.536.964.78Net Income-$64.73M$143.48M$3.23B$1.02B (ANTX) Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANTX(ANTX)N/A$1.08-11.9%$1.50+39.5%-46.0%$33.76MN/A-0.53N/AGLSIGreenwich LifeSciences2.2365 of 5 stars$9.38-3.0%$39.00+316.0%-38.0%$125.33MN/A-11.723ASMBAssembly Biosciences4.0391 of 5 stars$16.35+1.7%$33.00+101.9%+11.4%$124.84M$32.15M-2.62100Short Interest ↓HURATuHURA BiosciencesN/A$2.82-2.3%$12.67+350.0%N/A$123.44MN/A0.00N/ANews CoverageAnalyst DowngradeMGNXMacroGenics3.77 of 5 stars$1.95+19.1%$5.71+192.4%-67.5%$120.19M$152.43M-1.21430Positive NewsOptions VolumeHigh Trading VolumeTHTXTheratechnologiesN/A$2.60flatN/A+96.8%$119.55M$88.67M-26.00140Positive NewsCTNMContineum Therapeutics2.5534 of 5 stars$4.61+2.8%$22.50+388.6%-73.3%$119.37M$50M-2.3431ATOSAtossa Therapeutics1.4996 of 5 stars$0.91-1.0%$6.17+581.4%-32.5%$116.90MN/A-4.118BHSTBioHarvest SciencesN/A$6.98+0.3%$13.67+95.8%N/A$114.65M$27.70M-5.59N/AANIXAnixa Biosciences3.3749 of 5 stars$3.53+3.8%$9.00+155.0%+22.8%$112.90M$210K-8.995Analyst ForecastGap UpCRBPCorbus Pharmaceuticals3.9567 of 5 stars$9.10-1.2%$50.88+459.0%-83.3%$111.41MN/A-1.9440Positive NewsGap Down Related Companies and Tools Related Companies GLSI Competitors ASMB Competitors HURA Competitors MGNX Competitors THTX Competitors CTNM Competitors ATOS Competitors BHST Competitors ANIX Competitors CRBP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ANTX) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (ANTX) Please log in to your account or sign up in order to add this asset to your watchlist. Share (ANTX) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ANTX Stock Free ANTX Stock Alerts